| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Selling a Franchised Business |
|
Advice You - Selling a Franchised Business
Selling a franchise business is not as straight forward as selling your own business. Your franchise agreement will have detailed instructions on the procedures that According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product you need to follow when you take the opportunity to sell your business. These rules are there to protect both parties. The franchiser will be able to assist you in ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in valuing your business and will probably insist that you use the methods of valuation as set out in the franchise agreement. You will of course be free to seek indep lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. endent advice and valuations. Be careful when seeking the advice of experts and always agree the price beforehand so that you are prepared for the final costs and h here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ve a chance to negotiate any prices quoted before giving them the work. The rule of three quotes applies here as well. It is always worth seeking a second opinion a d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s valuations can vary wildly. This is due to the many variables the valuation experts take into account including future growth potential of your business and values ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc for any properties whether leased or purchased. The franchisee will have to seek the permission from the franchiser to sell the business. This permission can not b easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi unreasonably withheld or delayed provided that the franchisee has adhered to the terms of his agreement and has found a suitable buyer. In some cases the franchise nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e will have to pay a small percentage of the sale price to the franchiser. This can range from a standard fee to a percentage of the sales price. The franchisee will and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ also have to pay the franchiser a small fee to do the normal checks on the future buyer. The franchiser usually has a right to buy your franchise business at the s ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi me price as the highest offer received and considered acceptable. This is a normal part of any franchise agreement and is there to protect the franchisers rights. If ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a they believe that you are selling the business at under value, then they could take the opportunity to step in and buy the business for the same price. The franchi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ser might also want to take his business back into private control and this is an optimum time to buy the rights back. If this is the case then the franchiser might cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin actually step in and bid higher than the current highest offer. In most cases the new buyer will not be able to take over your franchise agreement. A new agreement tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ill have to be created for the new buyer and your agreement will lapse. You will have to ensure that all monies due as per the franchise agreement will have to be se t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ttled prior to the transaction taking place. Most franchisers will be able to assist you in the sale of your business if required. This service usually demands a pr ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust emium and or a higher percentage of the purchase price. Finally bear in mind that there is always a difference between the valuation and the final price achieved. I y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products some case this difference can be huge. In the end the market place will decide what your business is worth and not the valuation report. At any point in time some b . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de usiness are more in demand then others and can command prices well in excess of their valuation price. Taking all this into account it is better to sell the busines elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s when the economy is doing well or at the right side of the economic cycle. By getting the timing right, this can make a huge difference to the sales price achieved tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:9 Easy Steps to Implement Customer Service Policies that Decreases Risk The Worst Mistake People Make When Starting A Business Starting a Business - An Introduction to Starting Your Own Business
|